Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294514 · ClinicalTrials.gov registry record
Novel Non-Invasive Monitoring Parameter in Healthy Volunteers
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 27
- Enrollment target
NCT01294514: Completed study, sponsored by Medtronic - MITG.
NCT01294514 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01294514 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to study Non-Invasive Performance evaluation of monitoring algorithm.
Primary Outcome
Mean and standard deviations of respiration rates collected from healthy volunteers were compared between Covidien Respiration Rate Software, Transthoracic Impedance and Overscored End-Tidal Carbon Dioxide Waveforms. Each volunteer served as its own control.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-03 |
What the finished NCT01294514 record still lists
NCT01294514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01294514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01294514 about?
NCT01294514 is a clinical study titled "Novel Non-Invasive Monitoring Parameter in Healthy Volunteers". The purpose of this study is to study Non-Invasive Performance evaluation of monitoring algorithm.
What is the current status of trial NCT01294514?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-02. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT01294514?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia